tradingkey.logo
tradingkey.logo
Search

Cerus Corp

CERS
Add to Watchlist
3.160USD
+0.160+5.33%
Close 07/02, 13:00ETQuotes delayed by 15 min
633.00MMarket Cap
LossP/E TTM

TradingKey Stock Score of Cerus Corp

Currency: USD Updated: 2026-07-02

Key Insights

Cerus Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 50 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 4.50.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cerus Corp's Score

Industry at a Glance

Industry Ranking
50 / 204
Overall Ranking
131 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Cerus Corp Highlights

StrengthsRisks
Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 25.16% year-on-year.
Undervalued
The company’s latest PE is -64.24, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 147.40M shares, increasing 2.95% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 12.37M shares of this stock.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
4.500
Target Price
+50.00%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Cerus Corp?

The TradingKey Stock Score provides a comprehensive assessment of Cerus Corp based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Cerus Corp’s performance and outlook.

How do we generate the financial health score of Cerus Corp?

To generate the financial health score of Cerus Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Cerus Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Cerus Corp.

How do we generate the company valuation score of Cerus Corp?

To generate the company valuation score of Cerus Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Cerus Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Cerus Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Cerus Corp.

How do we generate the earnings forecast score of Cerus Corp?

To calculate the earnings forecast score of Cerus Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Cerus Corp’s future.

How do we generate the price momentum score of Cerus Corp?

When generating the price momentum score for Cerus Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Cerus Corp’s prices. A higher score indicates a more stable short-term price trend for Cerus Corp.

How do we generate the institutional confidence score of Cerus Corp?

To generate the institutional confidence score of Cerus Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Cerus Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Cerus Corp.

How do we generate the risk management score of Cerus Corp?

To assess the risk management score of Cerus Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Cerus Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Cerus Corp.